Antonio Giordano - Biotechnology

Author Information

Antonio Giordano is an esteemed researcher affiliated with the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, USA, as well as the Department of Medicine, Surgery and Neuroscience at the University of Siena in Italy. His work primarily focuses on cancer research and molecular medicine, contributing significantly to the field through numerous publications and innovative research studies.

Research Contributions

Antonio Giordano has made substantial contributions to the field of biotechnology, particularly in cancer research. His recent works include exploring advanced treatment options for mycosis fungoides and Sezary syndrome, identifying new PIN1 inhibitors, and evaluating the efficacy of second-line immunotherapy in mesothelioma. He has also investigated the role of Eribulin in metastatic breast cancer and the potential of therapeutic monoclonal antibodies for leukemia. His research spans various aspects of cancer treatment and diagnosis, including the use of circulating HPV DNA and microRNAs for managing cancers and the modulation of gene expression pathways.

Aliases

Antonio Giordano is also known in academic circles under the aliases A Giordano, A. Giordano, and A. Giordano. These variations are used interchangeably in his publications.

Publication and Citation Metrics

Metric	Value
Total Citations	32,486
H-index	87
Total Papers	851